PRODUCTION OF ANALGESICS, ANTIBIOTICS, ANTIFUNGAL AND ANTIRHEUMATIC MEDICAL PREPARATIONS
Operator/initiator: Kusum Uzbekistan LLC
Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park
Stage: The project is developed, contractors have not been yet determined
Dates: Execution period: 2026
Investment amount: Expected project cost: 5 million US dollars
PRODUCTION OF PREPARATIONS FOR PARENTERAL NUTRITION
Operator/initiator: MASMED PHARM IMPEX LLC
Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park
Stage: Requires development and approval of predesign and design documentation
Dates: Feasibility study development period: Q2 2023
Execution period: 2026
Investment amount: Expected project cost: 47 million US dollars
PRODUCTION OF BLOOD PLASMABASED MEDICINAL PREPARATIONS
Operator/initiator: Haematech
Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park
Stage: Requires development and approval of predesign and design documentation
Dates: Feasibility study development period: Q2 2023
Realisation period: 2026
Investment amount: Expected project cost: 85 million US dollars
ESTABLISHMENT OF THE TASHKENT PHARMA PARK INNOVATIVE R&D PHARMACEUTICAL CLUSTER (PHASE 1)
Including:
– Pharmaceutical university
– Pharmacopeia centre
– R&D centre
– Expertise centre
– BSL-3 Laboratory
– Vivarium
– Experimental production lines
Operator/initiator: Agency for the Development of the Pharmaceutical Industry of the Republic of Uzbekistan
Location: Tashkent region, Zangiatinsky district, Uzbekistan
Stage: Construction and commissioning of the administrative buildings of the Pharmaceutical Safety Centre and Development Directorate
Dates: Phase 1 is scheduled to be commissioned in November 2027
Investment amount: 130.2 million US dollars
The project is realised in order to stimulate the comprehensive development of the pharmaceutical industry in the country, including by expanding the range of pharmaceuticals produced, conducting research and development, and training personnel in the field of pharmaceuticals qualified in accordance with international educational standards. Financing of the project is provided by preferential funds of the EDCF Fund of the Eximbank of Korea, the Fund for Reconstruction and Development of the Republic of Uzbekistan, the Fund for Support and Development of the Pharmaceutical Industry and foreign direct investment. The modular structure of the cluster with a total area of 50 hectares involves the establishment of industrial, academic, research, clinical and preclinical sectors. The cluster will host production sites of leading pharmaceutical companies producing innovative medical products, medical devices and equipment, a multi-disciplinary research university and its components, research centres, a state centre of expertise of pharmaceutical products, a data centre and other necessary infrastructure.
CONSTRUCTION OF A MANUFACTURING FACILITY FOR THE PRODUCTION OF MEDICAL PREPARATIONS IN THE PARKENT FARM FEZ
Operator/initiator: Zuma Pharm
Location: Tashkent region, Zangiatinsky district, Uzbekistan
Stage: Phase 1 out of 4 is completed
Dates: 2028-2033
The Company is realising the project on the construction of a manufacturing facility for the production of medical preparations in the Parkent Farm FEZ. At the moment the 1st phase is completed – the production line for biological injectable medical preparations in syringes (ready to use) and lyophilic products in vials has been launched.
Subsequent phases of realisation:
• Phase 2: production of hormonal preparations in the form of pills.
• Phase 3: release of oncological preparations in the form of injections.
• Phase 4: blood factor preparations.
Realisation timeframe: 5-10 years.
PROJECT FOR THE CONSTRUCTION OF A PLANT FOR THE PRODUCTION OF INFUSIONS AND PP AMPOULES
Operator/initiator: Dora Line
Location: Tashkent Pharma Park
Stage: Realisation
Dates: 2026
Investment amount: 16 million US dollars
Useful project plot: 1.5 ha, 9000 m2.